Press release
Geriatric Medicines Market to Witness a Pronounce Growth During 2018 to 2026.
Geriatric Medicines Market
The Global Geriatric Medicines Market Size is anticipated to reach over USD 1,157.34 billion by 2026 according to a new research published by Polaris Market Research.
Geriatric medicines, also called geriatrics is a division of medicines associated with preventive, clinical, remedial, and social aspects of disease generally amongst people that are aged over 65 years or more. In response to the needs of an aging population, demand for geriatric medicines and appropriate cure has developed rapidly during last decades. The proper medical care for the geriatric patients across the range of ill health conditions includes co-morbid complications such as syncope, cerebral aging, and falls among others.
Request For Sample Copy of This Report @ http://bit.ly/2PTKwwe
The global geriatric medicines market is majorly driven by the factor including a rise in geriatric populations. According to the Eurostat, the number of people aged 65 years and above is expected reach 141 million by 2050 globally. In addition, the high market growth is expected on account of the increasing occurrence of numerous target disorders in the geriatric population, the demographic modification, the rising trend in lifestyle-associated risk aspects, and the considerably developed access to economic medicine across the developing and emerging regions. Continuous R&D activities commenced by key players and pharmaceutical companies to provide to the patient demand is expected to gain the significant outcomes during the forecast period. Increasing occurrence of chronic ailments, refining healthcare organization in emerging economies, increasing acceptance of medical tourism, government initiatives as well as support to provide timely care, and increasing number of specialty clinics are some of the other factors driving of the geriatric medicines market. However, difficulties associated with drug compatibility, lack of patient involvement in clinical trials, and side effects associated with the medications are the factors hampering the market growth.
The global Geriatric Medicines Market is segmented on the basis of therapeutic category, therapeutic condition, and geography.
Make an inquiry for purchasing this report @ http://bit.ly/2Q6fuBe
On the basis of therapeutic category, the global geriatric medicines market is segmented into Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant. Pain as an indication is associated with old age and the middle age population unveils the high occurrence rate of pain related syndromes. Based on current trends and the demand for proper therapy, the market is anticipated to witness high growth for therapeutic conditions during the forecast period. On the basis of therapeutic conditions, the global geriatric medicines market is segmented into Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory. In 2017, the cardiovascular disease is estimated to be the dominating segment primarily due to the high proliferation of several cardiac disorders such as coronary artery disease, stroke, and hypertension.
North America is estimated to dominate the global Geriatric Medicines Market. The existence of developed healthcare facilities, favorable reimbursement policies, and the easy availability of important as well as life-saving medicine has significantly enhanced the average life expectancy rates in North America. Moreover, the number of people that are over 65 to 70 years suffering several target ailments is increasing continually which is further anticipated to boost the geriatric medicines market during the forecast period.
Some major key players in global Geriatric Medicines Market include GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others.
Browse Complete Details @ http://bit.ly/2Q4ok2M
About us Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Contact us-
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
Follow us- LinkedIn | Twitter | Facebook
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Geriatric Medicines Market to Witness a Pronounce Growth During 2018 to 2026. here
News-ID: 1333426 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Anorexiants Market Expected to Attain US$ 1,403.13 Million by 2032, Maintaining โฆ
Growing consciousness about the genesis and solutions of obesity, together with the internet's availability to a broader consumer base, is disposed to ignite the acquisition of weight management drugs. Based on drug class analysis, the catecholamine's segment witnesses the highest growth. By region, in 2023, North America dominated the market with the largest share.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/anorexiants-market/request-for-sample
๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐ซ๐๐ฌ๐ฌ๐๐ฌ:
โข The global anorexiants market was valuedโฆ
North America Hearing AID Market size of USD 14.48 Billion in 2032, at a CAGR 6. โฆ
Polaris Market Research has recently published its latest research report titled "North America Hearing AID Market by Product (Hearing AID Devices and Hearing Implant), Type (Conductive Hearing Loss and Sensorineural Hearing Loss), Patient, Technology - Forecast to 2032." The study reveals that the market is anticipated to grow at a CAGR of 6.0%, reaching a market size of USD 14.48 billion in 2032 from the value of USD 8.58 billionโฆ
Vehicle Armor Materials Market Valuation to Hit US$ 10.10 Billion by 2032, Showi โฆ
Global vehicle armor materials market size and share is currently valued at USD 5.98 billion in 2023 and is anticipated to generate an estimated revenue of USD 10.10 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 6.2% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032
๐๐๐ข๐ง ๐๐ฆ๐ฆ๐๐๐ข๐๐ญ๐ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐จ ๐๐ฎ๐ซ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ:โฆ
Buy Now Pay Later Market Hits Milestone - Projected at USD 80.52 Billion By 2032 โฆ
Polaris Market Research's recent research demonstrates that the Buy Now Pay Later Market is expected to witness a steady CAGR of 29.20% during the forecast period. The market was valued at USD 8.05 billion in 2023 and is expected to grow to USD 80.52 billion by 2032. Growth can be linked to clients' strong preference for flexible payment options.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/buy-now-pay-later-market/request-for-sample
Buy now, pay later,โฆ
More Releases for Geriatric
Soaring Geriatric Demographic & Sophisticated Technology Buttress Geriatric Medi โฆ
Governmentsโ relentless pitch for all-round assistance for geriatric people along with technological advancements aimed at ameliorating medical assistance has underpinned the geriatric medicines market. One of the insurance programs in the United States named as the Federal Long Term Care Insurance Program has aptly incorporated near-to-full medical cost of the Americans. Factors such as longer life-expectancy, aging demographic, swelled awareness and adoption of sophisticated therapeutics are prophesized to propel theโฆ
Cataract Market Geriatric & Future Scenario 2025
Global Cataract Market: Snapshot
The incrementing demand in the global cataract market is a reflection of growing geriatric population, as people aged over 60 years frequently develop conditions wherein eyes have reduced elasticity and in turn affects the normal functioning. The market for cataract is also expected to gain from awareness programs such as VISION 2020, launched by the WHO and the International Agency for the Prevention of Blindness.
Request Sample Copyโฆ
Global Geriatric Drugs and Disease Management Market: High Incidence of Chronic โฆ
Researchmoz added Most up-to-date research on "Global Geriatric Drugs and Disease Management Market: High Incidence of Chronic Ailments among Geriatric Population Crea" to its huge collection of research reports.
Geriatric medicine refers to a branch of medicine dealing with the diagnosis, treatment and prevention of diseases in the elderly population. Increasing demand for geriatric care medication and services is attributed to increasing needs of the elderly population. The geriatric population suffersโฆ
Geriatric Medicines Market Analysis & Trends 2023
The global market for geriatric medicines stood at US$ 504.7 bn in 2014 and is projected to expand at a CAGR of 7.3 % during 2015โ2023. Rising at this pace, the opportunities in the market is anticipated to reach US$ 948.0 bn by the end of 2023.
Governmentsโ Push for Quality Geriatric Care Bodes Well for Market
The global geriatric medicines market is primarily driven the general rise in the elderly populationsโฆ
Consistent Rise in Geriatric Population is Expected to Stimulate the Growth of G โฆ
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions.
Complementary and alternative medicines include products such as dietary medicineโฆ
Consistent Rise in Geriatric Population is Expected to Stimulate Geriatric Compl โฆ
Geriatric Complementary and Alternative Medicines (CAM) Market: Overview
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions.
Browse to unlockโฆ
